Matthew Weston
Stock Analyst at UBS
(0.04)
# 4,160
Out of 4,749 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZN AstraZeneca | Upgrades: Neutral | n/a | $70.76 | - | 1 | Nov 20, 2024 |
AstraZeneca
Nov 20, 2024
Upgrades: Neutral
Price Target: n/a
Current: $70.76
Upside: -